Dipyridamole to prevent low phosphate after kidney transplant

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this Phase 2 interventional trial, adults who have received a kidney transplant will take dipyridamole 75 mg to see if it improves serum phosphate and lowers dependence on phosphate supplementation. The study targets reducing hypophosphatemia that can occur after transplantation. Participants are selected to exclude those with delayed graft function or who require certain anticoagulants. Stanford University leads the study with no listed collaborators. The trial location is Stanford, California.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult kidney transplant patients.
* No known contraindications to Dipyridamole

Exclusion Criteria:

* Contraindications to Dipyridamole.
* Patients with delayed graft function (defined as the need for dialysis within seven days post-transplantation).
* Patients requiring Plavix, direct oral anticoagulants (DOACs), or Coumadin.

Where it's running

• Stanford University
  Stanford, California, United States Recruiting

Study contacts

• Principal investigator: Stephan Busque, MD — Stanford University

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Italian Registry of Pediatric Dialysis: collecting data from kids on kidney replacement therapy

  This registry in Italy tests how collecting epidemiological, clinical, and treatment data from children on dialysis or pre-emptive kidney transplants can help centers share protocols and improve care.

  Recruiting at 12 sites Istituto Giannina Gaslini · Ancona and 11 other locations · NCT07918066

• Intraoperative diuretics during deceased-donor kidney transplants

  This trial tests whether using furosemide or mannitol during kidney transplant surgery affects delayed graft function in adults receiving a deceased-donor kidney.

  Recruiting London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · London, Ontario and 1 other locations · NCT07726134

• Immune Reset to Enable Kidney Transplant for Highly Sensitized Patients

  This study tests whether a temporary immune system reboot using a patient’s own stem cells can help highly sensitized kidney patients receive a compatible transplant.

  Recruiting Phase 1/2 Hospital Universitari Vall d'Hebron Research Institute · Barcelona, Catalonia · NCT07607197

• Home-based exercise to boost fitness for people waiting for a kidney transplant

  This study tests whether a 12-week, home-based exercise program plus a wearable activity tracker helps adults on the kidney transplant waiting list increase daily activity and improve physical function.

  Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT07446296

• A six-week online self-management program for adults in Israel with chronic conditions

  This six-week online group program will try to help adults in Israel who have chronic conditions—such as cancer survivors or kidney transplant recipients—learn practical skills to manage symptoms and daily health.

  Recruiting University of Haifa · Tel Aviv · NCT07367750

• Vonoprazan to reduce delayed graft function after deceased-donor kidney transplant

  This trial will test whether giving vonoprazan around the time of surgery lowers the chance of delayed graft function in adults receiving their first deceased-donor kidney transplant.

  Recruiting Phase 1/2 First Affiliated Hospital of Chongqing Medical University · Chongqing and 1 other locations · NCT07275632

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.